Kanra Joint Salvia Clinical observation of treatment of chronic hepatitis B.docVIP

 PAGE \* MERGEFORMAT 10 Kanra Joint Salvia Clinical observation of treatment of chronic hepatitis B Of: Jiang Yuanming, Zhao Chuan, Tang Kunlun [Abstract] Objective To observe the combined RSM Kanra chronic hepatitis B (CHB) of the patients. Methods 120 patients with chronic hepatitis B patients treated group, 60 patients received 80 mg Kanra injection in 5% glucose injection 250 mL in intravenous infusion, Danshen injection 20 mL in 5% glucose 250 mL intravenous injection, are 1 / d; the control group, 60 patients received Kanra injection, dose, treatment with the treatment group, two groups of drugs in the treatment of 20 days later to oral treatment was 6 months. After treatment, improvement of symptoms were observed and liver function markers. Results After treatment, symptoms were significantly improved liver function markers and liver fibrosis significantly improved liver function in treatment group and liver fibrosis indexes in more than the control group (P = lt;0.05 and 0.01). Kanra SM can significantly improve joint symptoms and liver function in hepatitis patients, and anti-fibrotic effects precise. [Keywords:] Chronic hepatitis B; Salvia; Kanra Abstract: Objective To observe the clinic effects of diisopropylamine dichloroacetate and salviae miltiorrhizae on chronic hepatitis B (CHB). Methods 120 patients, who suffer from CHB, were divided into two groups randomly. The treatment group (60 cases) were given compound diisopropylamine dichloroacetate (80 mg / day) combined with salviae miltiorrhizae composita (20 mL / day), and control group (60 cases) were only given compound diisopropylamine dichloroacetate (80mg/day). Both these 2 groups took medicine after 20 days drugs treatment, and the course would last for 6 months. The symptoms, the hepatic functions and the hepatic fibrosis index at the beginning, ending of the treatment were observed. Results After treatment, the patient s symptoms, sign and index of liver function and hepatic fi